BridgeBio Reports Third Quarter 2026 Financial Results and Corporate Updates
- $353.2 million in total third quarter revenues, primarily comprised of $253.2 million of U.S. Attruby net product revenue (up...
- $353.2 million in total third quarter revenues, primarily comprised of $253.2 million of U.S. Attruby net product revenue (up...
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) announced today that it...
Company to issue press release before market open; conference call to follow at 8:30 a.m. ETWILMINGTON, Del., Oct. 29, 2026...
– Phase 2 study will evaluate the safety, pharmacokinetics and antiviral activity of ABI-6250 in participants with chronic HDV infection...
Company to Host Conference Call with Live Q&A, November 12, 2026, at 4:30pm ET / 22:30 CET IRVINE, California –...
Neighbors, families, and community leaders filled the parking lot of the newest Ally Medical ER for an evening of food,...
Final positive readout for primary and several secondary endpoints presented by Federico Cappuzzo, MD, PhD, on October 25, 2026, at...
Funds that track these TASE benchmark indexes are expected to add Alpha Tau shares to their holdings TA-125 tracks the...
Free November 6–7 Community Wellness Seminar Explores Depression, Anxiety, Brain Health, and Cancer Through a Wholistic Approach to Health and...
LAUSANNE, Switzerland, Oct. 29, 2026 (GLOBE NEWSWIRE) -- VisioSurgical Solutions (VSS), a Swiss medical robotics company founded by the team...
LOS ANGELES, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical-stage biopharmaceutical company developing first-in-class therapies for cancer...
CEO Jonathan Cohen to Discuss Laboratory Franchise Model, 2027 Licensing Plans, Potential Acquisitions, FDA Strategy, and Firefighter Cancer Screening Initiatives...
Painletics App Turns a Short Quiz Into a Daily Routine for the Neck, Back and Joints Painletics Painletics NEW YORK,...
Management to host conference call and webcast at 4:30 pm ET on that day BOCA RATON, Fla, Oct. 29, 2026...
Decades of research address key considerations for healthcare professionals discussing non-hormonal menopause options with patientsRUEIL-MALMAISON, France, Oct. 29, 2026 (GLOBE...
Launch expands nationwide access to whole food-based nutritional supplements for dogs and cats PALMYRA, Wis., Oct. 29, 2026 (GLOBE NEWSWIRE)...
Milestone marks the culmination of years of grassroots fundraising inspired by the family’s matriarch Elsa Mendoza’s journey with MSNEW YORK,...
TGM-148 is designed to combine hemostatic efficacy with a favorable safety profile and low treatment burden Tangram’s second asset to...
Immunocore will present Phase 1 data for brenetafusp plus KIMMTRAK® (tebentafusp-tebn) in metastatic uveal melanoma, during a late-breaking oral session...
NEEDHAM, Mass., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical...